Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Regeneron (NASDAQ:REGN) Makes Pipeline Progress Crucial to Its Nasdaq 100 Healthcare Story

Regeneron (NASDAQ:REGN) has built a formidableBusinesson a handful of blockbuster medicines, but its future depends on what comes next. As its older products face growing competition, pipeline progress, turning laboratory science into approved, saleable drugs, is crucial to itsNasdaq100 healthcare story.

Nitish Kishor | 16 September 2026

SANGRIX (NASDAQ: SGRX) AI Transition Adds Website, Logo and Investor Contact

SANGRIX INC. (NASDAQ: SGRX) is repositioning its public identity around AI computing infrastructure with a new corporate website, logo and investor-relations contact.

Vinay Lochav | 16 September 2026

Five Nasdaq Health Names Balancing Clinical Catalysts and Compliance Clocks

● Synergy CHC disclosed aNasdaqnotice on 20 August 2026 for failing to timely file its Form 10-Q for the quarter ended 30 June 2026, with a compliance plan due by 19 October 2026.

Nitish Kishor | 16 September 2026

Vertex (NASDAQ:VRTX) Puts Expansion Beyond Cystic Fibrosis in the Spotlight

Vertex Pharmaceuticals (NASDAQ:VRTX) built a remarkableBusinessby dominating the treatment of a single rare disease, cystic fibrosis. Now the crucial question forNasdaq100 investors is whether it can repeat that success elsewhere, because itsLong-term Growthdepends on expanding beyond theFranchisethat made it, into new areas such as …

Nitish Kishor | 16 September 2026

D.R. Horton (NYSE: DHI) Authorizes Additional $5.0 Billion Stock Buyback

D.R. Horton, Inc. (NYSE: DHI) added $5.0 billion to its authorization for common-stock repurchases on September 15. The board-approved authorization has no expiration date.

Vinay Lochav | 16 September 2026

Driven Brands (NASDAQ: DRVN) Adds Shareholder Returns to Take 5 Growth Strategy

Driven Brands Holdings Inc. (NASDAQ: DRVN) has authorized up to $100 million in common stock repurchases, adding shareholder returns to its updated capital allocation priorities. The authorization took effect on September 15, 2026, while the company continues to invest in Take 5 growth.

Vinay Lochav | 16 September 2026

FG Nexus (NASDAQ: FGNX) Repurchased Common Shares Equaling 46% of Pre-Program Shares

FG Nexus Inc. (NASDAQ: FGNX) has repurchased approximately 4.0 million common shares for approximately $48.0 million, including commissions. Those purchases represent approximately 46% of the shares outstanding immediately before the common-stock program began.

Vinay Lochav | 16 September 2026

Bandwidth Inc. (NASDAQ: BAND) Plans 2026 Investor Presentation for Conferences

The materials will be available on the company’s investor-relations website and include discussion of cloud communications, AI voice and messaging.

Vinay Lochav | 16 September 2026

Alnylam Pharmaceuticals (NASDAQ:ALNY) Brings RNA-Based Medicines Into the Nasdaq 100 Growth Debate

Alnylam Pharmaceuticals (NASDAQ:ALNY) pioneered an entirely new class of medicine, drugs that silence disease-causing genes, and it is now turning that science into fast-growing commercial products. As those medicines reach more patients, Alnylam brings the promise of RNA-based therapies into theNasdaq100 growth debate, offering …

Nitish Kishor | 16 September 2026

Brenton John: Nano Dimension CFO Retains 403,762 Shares After Insider Transaction

Nano Dimension Ltd. CFO Brenton John forfeited 17,029 shares at $1.54 per share. The transaction was recorded on September 14, 2026.

Vinay Lochav | 16 September 2026
Support

Hi! How can we help you today?

Loading…